Area of Graduate Study:
· Drug Discovery and Design
· Molecular, Cellular and Integrative Pharmacology
Dr. Dwoskin's focus is the neuropsychopharmacology of the regulation of DA neuronal function, (i.e. control of DA release/reuptake into the presynaptic terminal, metabolism of DA, of dopamine (DA) functional responses induced by DA receptor stimulation, and the development of novel treatments for diseases involving DA pathophysiology, (i.e., Parkinson's disease, schizophrenia and drug abuse). DA is an important neurotransmitter for the control of motor movement, emotions. The role of genetics and environmental factors as determinants of responsiveness to drugs of abuse (psychostimulants: phencyclidine, amphetamine, cocaine and nicotine) and as determinants of abuse liability is a current focus.
Kristi W. Lopez, Last
Modified: March 14, 2002